CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-05 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −12,075 | $40.23 | $486K | 216,220 |
| 2023-06-05 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −296 | $40.74 | $12K | 215,924 |
| 2023-06-05 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −907 | $39.19 | $36K | 27,690 |
| 2023-06-05 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −3,019 | $40.23 | $121K | 24,671 |
| 2023-06-05 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −74 | $40.74 | $3K | 24,597 |
| 2023-06-05 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −16,000 | 827,556 | ||
| 2023-06-02 | Sturmer Michael E PRESIDENT | Shares withheld for taxes | −224 | $37.86 | $8K | 210,657 |
| 2023-06-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion 10b5-1 | +16,000 | $3.95 | $63K | 231,924 |
| 2023-06-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −16,000 | $38.67 | $619K | 215,924 |
| 2023-06-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −4,000 | $38.67 | $155K | 28,597 |
| 2023-06-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −16,000 | 843,556 | ||
| 2023-06-02 | Schlanger David J Executive Chairman | Exercise or conversion 10b5-1 | +41,667 | $0.91 | $38K | 115,154 |
| 2023-06-02 | Schlanger David J Executive Chairman | Sale 10b5-1 | −41,667 | $38.68 | $1.6M | 73,487 |
| 2023-06-02 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −41,667 | 398,894 | ||
| 2023-06-01 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −1,691 | $37.25 | $63K | 61,490 |
| 2023-06-01 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion 10b5-1 | +16,000 | $3.95 | $63K | 231,924 |
| 2023-06-01 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −10,795 | $37.41 | $404K | 221,129 |
| 2023-06-01 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −5,205 | $37.85 | $197K | 215,924 |
| 2023-06-01 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −2,699 | $37.41 | $101K | 33,898 |
| 2023-06-01 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,301 | $37.85 | $49K | 32,597 |
Page 22 of 77 · 1,524 trades